TG Therapeutics | TGTX - Market Capitalization


TG Therapeutics reported $5.46B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Amgen USD 176.25B 24.32B Dec/2025
Ardelyx USD 1.42B 89M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Corcept Therapeutics USD 3.66B 5.1B Dec/2025
Curis USD 3M 10M Apr/2026
Gilead Sciences USD 166.62B 14.34B Apr/2026
Infinity Pharmaceuticals USD 0 0 Apr/2026
J&J USD 561.65B 17.5B Apr/2026
Karyopharm Therapeutics USD 652M 517M Apr/2026
Novartis USD 234.78B 72.98B Apr/2026
Novavax USD 1.09B 316M Dec/2025
PTC Therapeutics USD 5.26B 844M Apr/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
Verastem USD 134M 462M Apr/2026
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025